⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MTVA News
MetaVia Inc. Common Stock
Form 8-K
sec.gov
MTVA
MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
prnewswire.com
MTVA
This Emerging Biotech Wave Could Create the Next Monster Healthcare Winners
globenewswire.com
AKTX
NTHI
MTVA
HCWB
MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia Reports First Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
MTVA
Form 8-K
sec.gov
MTVA
MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026
prnewswire.com
MTVA